文献速递免疫规划传染病防控与疫情报告

消除时代麻疹抗体下降:澳大利亚的经验

Declining measles antibodies in the era of elimination: Australia's experience.
PubMed 文献 · Vaccine · 2017-12-18

澳大利亚于2012—2013年开展全国血清学调查,检测1—49岁人群2729份残余血清的麻疹特异性IgG,并与1996—1999年、2002年、2007年三次调查比较趋势。结果显示1—49岁血清阳性率为80.8%(95%CI:79.4—82.3%),8.9%(95%CI:7.8—10.0%)抗体水平不确定,10—39岁血清阴性及不确定比例持续上升,R从1999年的0.57升至2012—2013年的1.7。

要点

  • 2012—2013年调查1—49岁麻疹IgG血清阳性率为80.8%(95%CI:79.4—82.3%)。
  • 10—39岁血清阴性及不确定比例持续上升,2—9岁不确定结果亦增加。
  • R从1999年0.57升至2012—2013年1.7,超过流行阈值1。

核心结论

  • 多个持续控制麻疹的国家已显示麻疹特异性IgG抗体随接种后时间下降,但人群水平保护的流行病学证据良好,抗体下降对维持消除的影响尚不明确。
  • 需要开展新研究以确定消除后时代麻疹传播和疾病的保护相关因素。

研究设计与样本

  • 2012—2013年开展全国血清学调查,检测1—49岁人群2729份残余血清的麻疹特异性IgG。
  • 采用Enzygnost抗麻疹IgG酶免疫测定(EIA),对复查仍不确定及随机抽取的低阳性和阴性血清用微量中和试验检测。
  • 用既往开发的接触矩阵按年龄计算血清阴性比例的加权估计值以推算R。
  • 与1996—1999年、2002年和2007年三次既往血清学调查结果比较趋势。

主要发现

  • 2012—2013年调查中1—49岁抗麻疹IgG血清阳性率为80.8%(95%CI:79.4—82.3%),8.9%(95%CI:7.8—10.0%)抗体水平不确定。
  • 10—39岁年龄组血清阴性和不确定个体比例增加,延续了既往血清学调查的趋势。
  • 2—4岁和5—9岁儿童不确定结果增加,其中>90%为近期接种。
  • R从1999年的0.57上升至2012—2013年超过流行阈值1的1.7。
  • 微量中和试验中,全部20份EIA阴性血清、238/241份(98.8%)不确定血清和89/92份(96.7%)低阳性血清滴度<10(阴性)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Australia is one of only a few countries with a long-standing and consistent serosurveillance program. We conducted a national serosurvey in 2012-2013 to estimate population seroprevalence of measles-specific IgG and the effective reproduction number, R, and compare the results with the three previous serosurveys (1996-1999, 2002 and 2007) to examine trends following a decade of sustained measles control. METHODS: 2729 residual sera from 1 to 49 year olds were tested using the Enzygnost anti-measles IgG enzyme immunoassay (EIA). All sera in the equivocal range by EIA on re-testing and a random sample of low positive and negative sera were later tested by a microneutralisation assay. R was calculated from weighted estimates of the proportion seronegative by age using a previously developed contact matrix. RESULTS: In the 2012-13 serosurvey, anti-measles IgG seropositivity for 1-49 year olds was 80.8% (95% CI: 79.4-82.3%) and 8.9% (95% CI: 7.8-10.0%) had equivocal antibody levels. The increasing proportion of seronegative and equivocal individuals in age groups 10-39 years continued a trend seen in previous serosurveys. There was also an increase in equivocal results among 2-4 and 5-9 year old children, >90% of whom were recently vaccinated. R increased from 0.57 in 1999 to above the epidemic threshold of 1 in 2012-13 (R = 1.7). All 20 EIA negative sera, 238/241 (98.8%) equivocal sera, and 89/92 (96.7%) low positive sera had a titre <10 (negative) in the measles microneutralisation assay. CONCLUSIONS: A number of countries with sustained measles control have now demonstrated that measles-specific IgG antibodies decline with time since vaccination. As there is good epidemiologic evidence of population-level protection, the implications of declining measles-specific IgG antibody levels for maintaining measles elimination are unclear. Novel studies to determine correlates of protection against measles transmission and disease in the post-elimination era are needed to help answer this question.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Gidding HF, Quinn HE, Hueston L, et al. Declining measles antibodies in the era of elimination: Australia's experience. Vaccine. 2017. PMID: 29269156. doi:10.1016/j.vaccine.2017.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。